货号:A1209598
同义名:
Antalarmin (hydrochloride); Antalarmin hydrochloride
Antalarmin (hydrochloride) 是一种非肽类促皮质素释放激素受体 1 (CRHR1) 拮抗剂,Ki 为 1 nM。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Antalarmin HCl is a non-peptide CRHR1 antagonist with a Ki value of 1 nM. Antalarmin HCl inhibits CRH-induced ACTH secretion, and blocks CRH- and novel-object-induced anxiety-like behaviours in animal model. Antalarmin HCl produces an anti-inflammatory effect in a model of arthritis and inhibits the pressure-induced gastric ulcers associated with irritable bowel syndrome[1][2][3]. |
| Concentration | Treated Time | Description | References | |
| COS-M6 cells | 10 µM | 15 min | Measure intracellular cAMP levels, Antalarmin blocks the constitutive activation of CRF(1–16)-R1DN chimera in a dose-dependent manner | Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10277-81 |
| dlBnST neurons | 40 or 4μM | 45 min | To test the effect of antalarmin on the frequency of GABA A receptor-mediated spontaneous inhibitory postsynaptic currents (sIPSCs). Results showed that antalarmin significantly reduced the frequency of sIPSCs in the AAS-treated group, reversing the AAS-induced enhancement of GABAergic inhibition. | Neuropsychopharmacology. 2012 May;37(6):1483-99 |
| Administration | Dosage | Frequency | Description | References | ||
| Balb/c mice | Orthotopic injection of 4T1 cells in the mammary fat pad to induce breast tumors | Intraperitoneal injection | 20 mg/kg | Daily for 6 weeks | To assess the impact of peripheral CRF inhibition on stress-induced tumor growth, results showed that Antalarmin suppressed stress-induced tumor growth and neoangiogenesis. | Mol Cancer. 2010 Sep 27;9:261 |
| Sprague-Dawley rats | Stress and anxiety-related behavior model | Intraperitoneal injection | 20 mg/kg | Single administration | To evaluate whether antalarmin could mitigate the attention deficits induced by PACAP. Results showed that antalarmin attenuated, but did not completely reverse, the effects of PACAP. | Biol Psychiatry. 2016 Dec 15;80(12):955-964 |
| Rats | Ethanol-dependent model | Intraperitoneal injection | 10 or 20 mg/kg | Single administration, 1 hour (80 minutes) prior to testing | Antalarmin significantly reduced ethanol self-administration in ethanol-dependent rats during acute withdrawal but had no effect in nondependent rats. | Biol Psychiatry. 2007 Jan 1;61(1):78-86 |
| Adult male rhesus macaques | Social stress model (intruder paradigm) | Oral | 20 mg/kg | Single dose, behavioral assessment 150 minutes post-administration | To evaluate the effects of Antalarmin on behavioral, neuroendocrine, and autonomic responses to stress in rhesus macaques. Results showed that Antalarmin significantly reduced anxiety and fear-related behaviors, increased exploratory and sexual behaviors, and significantly attenuated the increases in cerebrospinal fluid CRH as well as the pituitary-adrenal, sympathetic, and adrenal medullary responses to stress. | Proc Natl Acad Sci U S A. 2000 May 23;97(11):6079-84 |
| Mice | Environmental switch model | Intraperitoneal injection | 10 mg/kg | Twice daily for 7 days | Blockade of CRF1R completely eliminated the enhancement of cocaine rewarding effects induced by environmental switch | Neuropsychopharmacology. 2012 Jun;37(7):1579-87 |
| Rats | Swim stress model | Intraperitoneal injection | 32 mg/kg | Single administration, swim test lasted for 2 hours | To evaluate the effect of Antalarmin on cardiac vagal activity during swim stress. Results showed that Antalarmin significantly prolonged PR interval, induced severe bradycardia, and increased the percentage of sinking rats. These effects were blocked by methylatropine nitrate. | Neuropsychopharmacology. 2006 Dec;31(12):2580-90 |
| Wistar rats | Fear memory retrieval model | Intra-MRN injection | 250 ng | Single injection, 10 minutes before | To evaluate the role of CRF1 receptor in fear memory retrieval, results showed no significant effect of Antalarmin on freezing behavior | Neuropsychopharmacology. 2010 May;35(6):1271-8 |
| Female C57BL/6J mice | Chronic AAS exposure-induced anxiety-like behavior model | Intracerebroventricular (i.c.v.) infusion | 10 mg/kg | Single injection, 5 minutes before testing | To evaluate the blocking effect of antalarmin on AAS-induced anxiety-like behaviors. Results showed that antalarmin significantly blocked the AAS-induced increase in ASR amplitudes, indicating that CRF-R1 signaling plays a key role in AAS-induced anxiety. | Neuropsychopharmacology. 2012 May;37(6):1483-99 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.41mL 0.48mL 0.24mL |
12.05mL 2.41mL 1.20mL |
24.10mL 4.82mL 2.41mL |
|
| CAS号 | 220953-69-5 |
| 分子式 | C24H35ClN4 |
| 分子量 | 415.01 |
| SMILES Code | CC1=C(C)C2=C(N(CCCC)CC)N=C(C)N=C2N1C3=C(C)C=C(C)C=C3C.[H]Cl |
| MDL No. | MFCD05664721 |
| 别名 | Antalarmin (hydrochloride); Antalarmin hydrochloride |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 12 mg/mL(28.91 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 无水乙醇: 12 mg/mL(28.91 mM),配合低频超声,并水浴加热至45℃助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 DMF: 20 mg/mL(48.19 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1